Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amena Usmani

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Transfusion|May 9, 2024
A lower fibrinogen threshold does not lead to increased bleeding risk in patients receiving therapeutic plasma exchange: A prospective single-center analysisAmelework Wodajo, Ravi Sarode, Shiney Valiyaparambil, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|August 3, 2020
Comparison of low fixed dose versus standard-dose rituximab to treat thrombotic thrombocytopenic purpura in the acute phase and preemptively during remissionManasa S Reddy, Sandra Hofmann, Yu Min Shen, et al.
Journal of Clinical Apheresis|March 1, 2021
Immune checkpoint inhibitor toxicity: A new indication for therapeutic plasma exchange?Frances Compton, Lin He, Ravi Sarode, et al.
Vaccines|July 2, 2021
Serological Response in Lung Transplant Recipients after Two Doses of SARS-CoV-2 mRNA VaccinesMadhusudhanan Narasimhan, Lenin Mahimainathan, Andrew E Clark, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|April 6, 2022
Does Immunohistochemistry Add to Morphology in Differentiating Trichoepithelioma, Desmoplastic Trichoepithelioma, Morpheaform Basal Cell Carcinoma, and Microcystic Adnexal Carcinoma?Sambit K Mohanty, Ruhani Sardana, Michael McFall, et al.
Transplantation|October 1, 2025
Characterization of Spirometric Response to Standard-of-care Treatment in Lung Allograft Recipients With Bronchiolitis Obliterans and the Utility of Spirometric Criteria for Rescue Therapy: Implications for the Design of Risk-stratified Clinical TrialsDerek E Byers, Ramsey Hachem, Chadi A Hage, et al.
Transplantation Direct|September 24, 2025
Identification of Surrogate Outcome Biomarkers in Lung Allograft Recipients With Bronchiolitis Obliterans: Implications for Randomized Controlled TrialsDerek E Byers, Ramsey Hachem, Chadi A Hage, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Transfusion|May 9, 2024
A lower fibrinogen threshold does not lead to increased bleeding risk in patients receiving therapeutic plasma exchange: A prospective single-center analysisAmelework Wodajo, Ravi Sarode, Shiney Valiyaparambil, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|August 3, 2020
Comparison of low fixed dose versus standard-dose rituximab to treat thrombotic thrombocytopenic purpura in the acute phase and preemptively during remissionManasa S Reddy, Sandra Hofmann, Yu Min Shen, et al.
Journal of Clinical Apheresis|March 1, 2021
Immune checkpoint inhibitor toxicity: A new indication for therapeutic plasma exchange?Frances Compton, Lin He, Ravi Sarode, et al.
Vaccines|July 2, 2021
Serological Response in Lung Transplant Recipients after Two Doses of SARS-CoV-2 mRNA VaccinesMadhusudhanan Narasimhan, Lenin Mahimainathan, Andrew E Clark, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|April 6, 2022
Does Immunohistochemistry Add to Morphology in Differentiating Trichoepithelioma, Desmoplastic Trichoepithelioma, Morpheaform Basal Cell Carcinoma, and Microcystic Adnexal Carcinoma?Sambit K Mohanty, Ruhani Sardana, Michael McFall, et al.
Transplantation|October 1, 2025
Characterization of Spirometric Response to Standard-of-care Treatment in Lung Allograft Recipients With Bronchiolitis Obliterans and the Utility of Spirometric Criteria for Rescue Therapy: Implications for the Design of Risk-stratified Clinical TrialsDerek E Byers, Ramsey Hachem, Chadi A Hage, et al.
Transplantation Direct|September 24, 2025
Identification of Surrogate Outcome Biomarkers in Lung Allograft Recipients With Bronchiolitis Obliterans: Implications for Randomized Controlled TrialsDerek E Byers, Ramsey Hachem, Chadi A Hage, et al.
Pageof 2